颅内原发Rosai-Dorfman病1例报告

2018-09-27 赵新炜 闫会昌 毛冲冲 河南医学研究

Rosai-Dorfman病为一种罕见组织细胞增生性疾病,又被称为窦组织细胞增生伴淋巴结病,于1969年首次报道,原发于颅内病例罕见,国内报道不足30例。颅内原发Rosai-Dorfman病易误诊为脑膜瘤后手术切除,经病理学检查确诊,该病变组织细胞S-100蛋白和CD68表达阳性为可靠诊断依据。

Rosai-Dorfman病为一种罕见组织细胞增生性疾病,又被称为窦组织细胞增生伴淋巴结病,于1969年首次报道,原发于颅内病例罕见,国内报道不足30例。颅内原发Rosai-Dorfman病易误诊为脑膜瘤后手术切除,经病理学检查确诊,该病变组织细胞S-100蛋白和CD68表达阳性为可靠诊断依据。
 
患者男性,53岁,因右侧枕部钝痛6个月入院。查体:神经系统未见异常,无皮肤红肿结节,全身淋巴结未见肿大。头颅MRI及血管成像示:①右侧枕部实性占位,考虑脑膜瘤;②双侧上颌窦、双侧筛窦炎并双侧上颌窦、左侧筛窦囊肿;③脑MRV提示右侧枕部病变与右侧横窦与窦汇交界区关系密切(见图1)。
 
图1  术前MRI。A:增强后病变明显均匀强化,邻近中线;B:病变与小脑幕联系密切,脑膜尾征明显。
 
C反应蛋白1.3mg/L、降钙素原0.064ng/ml。血常规正常。因病变在影像学上符合脑膜瘤特征,行右侧枕部占位切除术,术中发现病变与周围组织分界不清,占位效应明显,镜下切除后见肿瘤附着于横窦及窦汇外侧壁。术中病理快速冰冻结果:镜下见脑组织,部分区域胶质细胞增生伴较多淋巴细胞浆细胞浸润及血管增生,炎症不除外。(右枕部窦口)镜下见脑组织,部分区域纤维组织增生,伴较多淋巴细胞、浆细胞、泡沫细胞浸润及血管增生,符合炎性病变(见图2),免疫组化:CD68(+),S-100(+),诊断为Rosai-Dorfman病。患者术后神志清醒,痊愈后出院,未给予药物治疗及放化疗,术后3个月复查MRI可见病灶消失,未复发(见图3)。

图2  病理切片。C:镜下见大量淋巴细胞、浆细胞、泡沫细胞浸润;D:组织细胞间可有各种炎性细胞弥漫浸润,由于纤维化及血管增生。
 
图3  术后3月MRI(病变组织消失)
 
原始出处:

赵新炜,闫会昌,毛冲冲,刘俊,王艳敏,刘献志. 颅内原发Rosai-Dorfman病1例报告及文献回顾[J]. 河南医学研究,2017,26(06):1022-1023.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1931657, encodeId=1556193165e11, content=<a href='/topic/show?id=538d6192ed' target=_blank style='color:#2F92EE;'>#Dorfman#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6192, encryptionId=538d6192ed, topicName=Dorfman)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58df296, createdName=shock_melon, createdTime=Mon Aug 12 10:48:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642586, encodeId=58291642586e2, content=<a href='/topic/show?id=8b2b15639e1' target=_blank style='color:#2F92EE;'>#Rosai-Dorfman病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15639, encryptionId=8b2b15639e1, topicName=Rosai-Dorfman病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07c522973206, createdName=ms3297076796458174, createdTime=Wed Jan 23 22:48:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349776, encodeId=c3031349e7648, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364392, encodeId=5af61364392ec, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346986, encodeId=6c9b34698654, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Sep 27 22:36:24 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1931657, encodeId=1556193165e11, content=<a href='/topic/show?id=538d6192ed' target=_blank style='color:#2F92EE;'>#Dorfman#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6192, encryptionId=538d6192ed, topicName=Dorfman)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58df296, createdName=shock_melon, createdTime=Mon Aug 12 10:48:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642586, encodeId=58291642586e2, content=<a href='/topic/show?id=8b2b15639e1' target=_blank style='color:#2F92EE;'>#Rosai-Dorfman病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15639, encryptionId=8b2b15639e1, topicName=Rosai-Dorfman病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07c522973206, createdName=ms3297076796458174, createdTime=Wed Jan 23 22:48:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349776, encodeId=c3031349e7648, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364392, encodeId=5af61364392ec, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346986, encodeId=6c9b34698654, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Sep 27 22:36:24 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1931657, encodeId=1556193165e11, content=<a href='/topic/show?id=538d6192ed' target=_blank style='color:#2F92EE;'>#Dorfman#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6192, encryptionId=538d6192ed, topicName=Dorfman)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58df296, createdName=shock_melon, createdTime=Mon Aug 12 10:48:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642586, encodeId=58291642586e2, content=<a href='/topic/show?id=8b2b15639e1' target=_blank style='color:#2F92EE;'>#Rosai-Dorfman病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15639, encryptionId=8b2b15639e1, topicName=Rosai-Dorfman病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07c522973206, createdName=ms3297076796458174, createdTime=Wed Jan 23 22:48:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349776, encodeId=c3031349e7648, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364392, encodeId=5af61364392ec, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346986, encodeId=6c9b34698654, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Sep 27 22:36:24 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
    2018-09-29 bioon3
  4. [GetPortalCommentsPageByObjectIdResponse(id=1931657, encodeId=1556193165e11, content=<a href='/topic/show?id=538d6192ed' target=_blank style='color:#2F92EE;'>#Dorfman#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6192, encryptionId=538d6192ed, topicName=Dorfman)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58df296, createdName=shock_melon, createdTime=Mon Aug 12 10:48:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642586, encodeId=58291642586e2, content=<a href='/topic/show?id=8b2b15639e1' target=_blank style='color:#2F92EE;'>#Rosai-Dorfman病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15639, encryptionId=8b2b15639e1, topicName=Rosai-Dorfman病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07c522973206, createdName=ms3297076796458174, createdTime=Wed Jan 23 22:48:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349776, encodeId=c3031349e7648, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364392, encodeId=5af61364392ec, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346986, encodeId=6c9b34698654, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Sep 27 22:36:24 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
    2018-09-29 lsndxfj
  5. [GetPortalCommentsPageByObjectIdResponse(id=1931657, encodeId=1556193165e11, content=<a href='/topic/show?id=538d6192ed' target=_blank style='color:#2F92EE;'>#Dorfman#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6192, encryptionId=538d6192ed, topicName=Dorfman)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58df296, createdName=shock_melon, createdTime=Mon Aug 12 10:48:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642586, encodeId=58291642586e2, content=<a href='/topic/show?id=8b2b15639e1' target=_blank style='color:#2F92EE;'>#Rosai-Dorfman病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15639, encryptionId=8b2b15639e1, topicName=Rosai-Dorfman病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07c522973206, createdName=ms3297076796458174, createdTime=Wed Jan 23 22:48:00 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349776, encodeId=c3031349e7648, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364392, encodeId=5af61364392ec, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sat Sep 29 12:48:00 CST 2018, time=2018-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346986, encodeId=6c9b34698654, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Sep 27 22:36:24 CST 2018, time=2018-09-27, status=1, ipAttribution=)]
    2018-09-27 医者仁心5538

    学习了

    0

相关资讯

63岁男性颅内肿瘤,如何诊断?

患者男,63岁。主诉:头痛2月余,记忆力减退10余天。

急诊颅内血肿清除术中超声诊断对冲性迟发血肿1例

患者,男,44岁,主因“骑摩托车摔伤后伴头痛、双侧外耳道流血、恶心呕吐1个多小时”,于2014年11月21日14:34急诊入院。

开颅术后并发泛耐药鲍曼不动杆菌性颅内感染病例

女,41岁。因“突发头痛、神志不清半小时”于2016年6月13日入院。

7种颅内感染性病变CT表现

各种颅内感染性病变CT片子……

多次复发颅内孤立性纤维瘤1例

患者男,26岁,因头晕头痛不适于2011年11月初次就诊

颅内恶性肿瘤占位病变1例

患者,男,62岁 ,不明原因头痛、呕吐一月余